SE8604270D0 - Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden, samt satsens anvendning - Google Patents

Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden, samt satsens anvendning

Info

Publication number
SE8604270D0
SE8604270D0 SE8604270A SE8604270A SE8604270D0 SE 8604270 D0 SE8604270 D0 SE 8604270D0 SE 8604270 A SE8604270 A SE 8604270A SE 8604270 A SE8604270 A SE 8604270A SE 8604270 D0 SE8604270 D0 SE 8604270D0
Authority
SE
Sweden
Prior art keywords
polypeptide
kit
pancreasoamyloid
kats
antibodies targeted
Prior art date
Application number
SE8604270A
Other languages
English (en)
Other versions
SE454299B (sv
Inventor
Per Westermark
Kenneth H Johnson
Original Assignee
Westermark P
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Westermark P, Univ Minnesota filed Critical Westermark P
Priority to SE8604270A priority Critical patent/SE454299B/sv
Publication of SE8604270D0 publication Critical patent/SE8604270D0/sv
Priority to AU81012/87A priority patent/AU8101287A/en
Priority to PCT/SE1987/000452 priority patent/WO1988002863A1/en
Priority to EP87850300A priority patent/EP0263802B1/en
Priority to JP62506094A priority patent/JP2863527B2/ja
Priority to ES87850300T priority patent/ES2072252T3/es
Priority to AT87850300T priority patent/ATE123147T1/de
Priority to CA000548777A priority patent/CA1341222C/en
Priority to DE3751316T priority patent/DE3751316T2/de
Publication of SE454299B publication Critical patent/SE454299B/sv
Priority to US07/516,329 priority patent/US5116948A/en
Priority to US07/658,442 priority patent/US5112945A/en
Priority to US07/838,043 priority patent/US5298605A/en
Priority to US08/183,150 priority patent/US5424221A/en
Priority to JP8199912A priority patent/JP2939439B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/845—Pancreas
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
SE8604270A 1986-10-08 1986-10-08 Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden SE454299B (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE8604270A SE454299B (sv) 1986-10-08 1986-10-08 Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden
PCT/SE1987/000452 WO1988002863A1 (en) 1986-10-08 1987-10-07 Kit of material containing a polypeptide of pancreatic islet amyloid and/or antibodies directed against said polypeptide; and use of said kit of material
AT87850300T ATE123147T1 (de) 1986-10-08 1987-10-07 Materialzusammensetzung, welche ein polypeptid aus pankreas-insel-amyloid und/oder antikörpern gegen dieses polypeptid enthält, und anwendung dieser zusammensetzung.
DE3751316T DE3751316T2 (de) 1986-10-08 1987-10-07 Materialzusammensetzung, welche ein Polypeptid aus Pankreas-Insel-Amyloid und/oder Antikörpern gegen dieses Polypeptid enthält, und Anwendung dieser Zusammensetzung.
EP87850300A EP0263802B1 (en) 1986-10-08 1987-10-07 Kit of material containing a polypeptide of pancreatic islet amyloid and/or antibodies directed against said polypeptide, and use of said kit of material
JP62506094A JP2863527B2 (ja) 1986-10-08 1987-10-07 膵島アミロイドポリペプチド
ES87850300T ES2072252T3 (es) 1986-10-08 1987-10-07 Estuche de material que contiene un polipeptido de amiloide de los islotes y/o anticuerpos dirigidos contra dicho polipeptido, y uso de dicho estuche de material.
AU81012/87A AU8101287A (en) 1986-10-08 1987-10-07 Kit of material containing a polypeptide of pancreatic islet amyloid and/or antibodies directed against said polypeptide; and use of said kit of material
CA000548777A CA1341222C (en) 1986-10-08 1987-10-07 Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp
US07/516,329 US5116948A (en) 1986-10-08 1990-04-30 Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp
US07/658,442 US5112945A (en) 1986-10-08 1991-02-21 Preparation of islet amyloid polypeptides (iapp) and antibodies to iapp
US07/838,043 US5298605A (en) 1986-10-08 1992-02-19 Antibodies to islet amyloid polypeptide (IAPP) and subunits thereof
US08/183,150 US5424221A (en) 1986-10-08 1994-01-18 Kit for detection of islet amyloid polypeptide (IAPP)
JP8199912A JP2939439B2 (ja) 1986-10-08 1996-07-30 膵島アミロイドポリペプチドに対する抗体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8604270A SE454299B (sv) 1986-10-08 1986-10-08 Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden

Publications (2)

Publication Number Publication Date
SE8604270D0 true SE8604270D0 (sv) 1986-10-08
SE454299B SE454299B (sv) 1988-04-18

Family

ID=20365860

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8604270A SE454299B (sv) 1986-10-08 1986-10-08 Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden

Country Status (10)

Country Link
US (2) US5116948A (sv)
EP (1) EP0263802B1 (sv)
JP (2) JP2863527B2 (sv)
AT (1) ATE123147T1 (sv)
AU (1) AU8101287A (sv)
CA (1) CA1341222C (sv)
DE (1) DE3751316T2 (sv)
ES (1) ES2072252T3 (sv)
SE (1) SE454299B (sv)
WO (1) WO1988002863A1 (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298605A (en) * 1986-10-08 1994-03-29 Regents Of The University Of Minnesota Antibodies to islet amyloid polypeptide (IAPP) and subunits thereof
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
US5367052A (en) * 1987-04-27 1994-11-22 Amylin Pharmaceuticals, Inc. Amylin peptides
GB8709871D0 (en) * 1987-04-27 1987-06-03 Turner R C Peptides
US5266561A (en) * 1988-01-11 1993-11-30 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus
US5175145A (en) * 1988-08-26 1992-12-29 Amylin Pharmaceuticals, Inc. Treatment of diabetes mellitus with amylin agonists
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5352771A (en) * 1992-08-31 1994-10-04 Iowa State University Research Foundation Inc. Hydrolysis of peptide bonds using Pt (II) and Pd (II) complexes
US5376638A (en) * 1992-09-01 1994-12-27 Amylin Pharmaceuticals, Inc. Methods for treating renin-related disorders with amylin antagonists
WO1996002269A1 (en) * 1994-07-13 1996-02-01 Auckland Uniservices Limited Therapeutic method and compounds of use therein
US6087129A (en) 1996-01-19 2000-07-11 Betagene, Inc. Recombinant expression of proteins from secretory cell lines
US6821954B2 (en) 1997-09-18 2004-11-23 Auckland Uniservices Limited Compounds and uses thereof in treating bone disorders
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
CN101010590A (zh) * 2004-07-28 2007-08-01 弗·哈夫曼-拉罗切有限公司 胰多肽作为β细胞衰竭的靶标/标记物
DE102004051014A1 (de) * 2004-10-20 2006-04-27 Rwth Aachen Chemisch modifizierte Peptidanaloga

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE500044C2 (sv) * 1985-02-15 1994-03-28 Gambro Lundia Ab Peptidförening, antiserum framställt med användning av denna förening samt användning av föreningen
GB8516081D0 (en) * 1985-06-25 1985-07-31 Ciba Geigy Ag Assay & purification of amyloid components
GB8709871D0 (en) * 1987-04-27 1987-06-03 Turner R C Peptides

Also Published As

Publication number Publication date
CA1341222C (en) 2001-05-01
ATE123147T1 (de) 1995-06-15
WO1988002863A1 (en) 1988-04-21
US5112945A (en) 1992-05-12
JPH09119929A (ja) 1997-05-06
JP2863527B2 (ja) 1999-03-03
AU8101287A (en) 1988-05-06
EP0263802B1 (en) 1995-05-24
JP2939439B2 (ja) 1999-08-25
DE3751316T2 (de) 1996-02-01
US5116948A (en) 1992-05-26
EP0263802A1 (en) 1988-04-13
SE454299B (sv) 1988-04-18
JPH02500857A (ja) 1990-03-22
ES2072252T3 (es) 1995-07-16
DE3751316D1 (de) 1995-06-29

Similar Documents

Publication Publication Date Title
SE8604270D0 (sv) Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden, samt satsens anvendning
DE68921320D1 (de) Flüssiger elektrophotographischer Entwickler.
BR8704936A (pt) Composicao de polimento de vidros organicos contendo oxido cerico
DE68911750D1 (de) Druckgerät und System zur Abgabe von Toner/Entwickler dafür.
SE8206168L (sv) Peptidpreparat
DK98681A (da) Proteinmaterialer samt fremgangsmaade til deres fremstilling
PT90574A (pt) Processo de preparacao de polipeptidos e de determinacao da presenca de anticorpos de proteina latente anti-virus do papiloma
DE68917323D1 (de) Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine.
DK521386A (da) Fremgangsmaade til bestemmelse af aminosyre-sekvensen af et polypeptid, som er komplementaert til et peptid eller protein eller en del heraf, samt middel til brug ved fremgangsmaaden
DE3650135D1 (de) Proteingewinnung.
NO881904L (no) Fremgangsmaate til selektiv immunologisk bestemmelse av intakt prokollagen peptid (type iii) og prokollagen (type iii) i kroppsvaesker, og middel til dets gjennomfoering.
DK267480A (da) Proteolytisk middel til proteinhydrolyse samt proteinhydrolyseproces
KR900004935A (ko) 슈도 모나즈 아에루기노사의 지질단백질 i(ompi)
FI882680A (fi) Substituerade 3-(4-nitrofenoxi) pyrazoler och deras anvaendning som herbicider.
NZ220398A (en) A reagent for rendering biological media transparent and its use for analysis of these
EP0293827A3 (en) Assay for leishmaniasis
DE68919697D1 (de) Katalytische hydrofluorierung von alkenen.
DK21586A (da) Antigener og antistoffer samt praeparater indeholdende disse
FI881122A (sv) Förfarande för isolering av glashinneproteiner ur människo- och djurvävnad
DE68924039D1 (de) Flüssige Entwickler für Elektrophotographie.
DE3886971D1 (de) Hochkontrastreicher Positiv-Photolack-Entwickler mit Alkanolamin.
DK116487D0 (da) Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser.
DE3875479D1 (de) Elektrofotografisches vervielfaeltigungsgeraet mit mehreren betriebsarten.
PT87376A (pt) Monoklonaler antikoerper zur selektiven immunologischen bestimmung von intaktem prokollagen peptid (typ iii) und prokollagen (typ iii) in koerperfluessigkeiten
ATE114818T1 (de) Immuntest zum nachweis von alpha-haloacetamiden.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8604270-2

Format of ref document f/p: F

NUG Patent has lapsed